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Anti-SS-B/La and anti-SS-A/Ro antibodies coexist in 
certain patients with connective tissue diseases such as 
systemic lupus erythematosus or Sjogren's syndrome. 
The respective antigenic structures with which these 
autoantibodies bind have not been fully characterized. 
The present study was conducted to better define these 
two different cellular antigens. WiL2 cell extracts were 
used to obtain partially purified SS-B/La and SS-A/Ro 
antigens. Both were found to be present in most frac-
tions obtained after sequential purification with am-
monium sulfate salt precipitation, G-200 gel filtration, 
DE-52 ion exchange chromatography, and preparative 
slab gel electrophoresis. However, SS-B/La antigenic 
activity was also found to be present in some fractions 
that did not contain detectable SS-A/Ro activity . These 
findings suggested the existence of two different forms 
of SS-B/La antigen: one containing the SS-B/La antigen 
only and the other containing both the SS-B/La and SS-
A/Ro antigens. The RNA and protein components of 
these two ribonuclear protein particles were further 
defined by immunoprecipitation experiments using '12P-
Jabeled WiL2 cell extract. The SS-B/La antigen was 
found to be associated with several RNAs while the SS-
A/Ro antigen was associated with several other distinct 
RNAs. Both antibodies precipitated a common 43K mo-
lecular weight phosphoprotein. The antigenic peptides 
of these 2 antibodies were analyzed using an immunoblot 
system. The SS-B/La antigen was present on a 43K 
peptide which was unstable and could be degraded to 
several peptides of lower molecular weight (40K, 38K, 
30K), while the SS-A/Ro antigen occurred on a peptide 
having a molecular weight of about 60K. 
Autoantibodies, especially antinuclear antibod ies, are pres-
ent in patients with various con nective t issue diseases. Some 
of these ant ibodies are highly characte ri stic fo r ce rta in diseases. 
For exam ple, a nti -nDNA and anti -Sm antibodies are charac-
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teristic of systemic lupus erythematosus (SLE), while anticen-
tromeric antibodies are highly specific for the CREST syn -
drome. Many of these autoantibodies, however, are not disease-
specific and can be present in patients in different clinical 
settings. Anti-nRNP antibodies, for example, can be seen in 
patients with SLE, rheumatoid arthritis, Sjogren's syndrome 
and mixed connective tissue disease. Though such autoantibod~ 
ies are not disease-specitic , t hey can be important laboratory 
tools for studying cell structure and events related to cellular 
metabolism. Previously anticentromeric antibodies have been 
used in this way to localize the centromere in nuclei of cells 
during the resting phase of the cell cycle [1). Antibodies against 
nonhistone nuclear components such as Sm, nRNP, and SS-
B/La have also been used to ga in a better understanding of the 
cellula r distribution of their respective antigens. For example, 
our earlier stud ies have shown that SS-B/La antigen is present 
in the nucleoplasm of cell s in the resting phase and in the 
nucleoplasm and nucleo lus of cells in the late G 1 to ea rly S 
phase of the ce ll cycle [2). 
These autoantibod ies have a lso been used to study the small 
ce ll ula r RNAs. In 1979, Lerne r and Steitz repo rted t hat anti-
Sm and anti-nRNP containing sera specifica lly precipitated 
the uridine-enriched nuclear RNAs call ed U1, U2, U4, U5, and 
U6 \3]. Subsequent ly Lerner et a l reported that other uniden-
tified ce llular RNAs were prec ipitated by anti-La/SS-B and 
anti-Ro/SS-A se ra [4) . In addition, anti-SS-B/La se ra a lso 
prec ipitated adenov irus-associated RNA (VA-RNA) [ 4) and 
Epstein-Ba rr virus-associated RNAs (E8ER) [5). Further char-
acterization of the SS-B/ La and SS-A/Ro ribonucleoproteins 
showed that the small RNAs are mainly products of RNA 
polyme rase III [6,7 ). Recently, experiments have indicated t hat 
the SS-B/La antige n is involved in the maturation of RNA 
polymerase Ill transcripts and a lso binds to precursors of 58 
ribosomal RNA [6 ,8,9]. 
SS-B/La and SS-A/Ro antigens are thought to be very 
soluble cellular p roteins and sensitive to trypsin [10- 14). Mo-
lecular weight of the SS-B/La antigen-bearing protein has been 
var iously estimated as 30K, 40- 45K, 50K, aod 67K [8,10,13,15-
19] . Recent data did suggest that SS-B/La antigen was a 
peptide of around 45K [16,17,19] and a lso a phosphoprotein 
[15). Molecu lar weight of SS-A/Ro was estimated to be 48K, 
150K, or 60K [14,19,20]. There still is much confusion concern-
ing the molecular characteristics of SS-B/La and SS-A/Ro 
antigens. 
Antibodies to SS-8/La and SS-A/Ro have been found to 
coexist frequently in patients with SLE or Sjogren's syndrome 
[10]. Their mutual occurrence is simila r to what has been 
observed for anti-Sm and anti -nRNP antibodies in certain SLE 
patients. Recent studies have shown that both Sm and nRNP 
antigenic particles share one common RNA- UI RNA (3]. It 
has a lso been shown that there exist two forms of Sm antigen. 
One is free a nd the other consists of a complex of Sm and 
nRNP. These observations suggest that a similar kind of mo-
lecular interaction between SS-8/La and SS-A/Ro might a lso 
exist. Hendrick et al have shown that the SS-A/Ro particle 
ca rries the SS-B/La as well as the SS-A/Ro determinant (6). 
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The ir study suggested t hat t he re a re t wo forms of SS-B/L a 
a n t ige n , o ne co n taining only t he SS- B/ La dete rminant a nd t he 
othe r con taining both SS-B / L a a nd SS-A/ R o dete rmin a n ts. 
A fur t he r cl a rification o f t hese issues is required in o rde r to 
gain a better understanding of t he no rma l physio logic ro le 
played by t hese s ma ll RNP pa r t icles a nd a ny pathophysio logic 
a lte ratio n that a n t ibodies to t hese parti c les mi gh t produce. 
H e re, we repo rt fur t her bioc hemical ch a rac te ri zation of SS-B/ 
La and SS-A/ Ro a ntige nic molecules ext racted from WiL2 
ce ll s. 
MATE RIALS AND ME THODS 
Sera 
Se ra co nta ining monospec ifi c antibodies we re obt a ined from patients 
wi t h S LE, subacute cutaneous lu pus erythematosus, mixed connective 
t issue disease, or primary Sjogren's syndrome. The monospecificity of 
t hese sera was based on t.he fac t. th at each serum produced only one 
precipi t in line on double immunodiffusion and counterimmunoelectro-
phoresis using rabbit thymus extract and WiL2 cell extrac t as t he 
ant ige nic sources. The monospecificit y oft he sera conta ining only anti -
SS-A/ Ro antibodi es was a lso ubBtant iated by the fact tha t they gave 
a negative flu orescent antinuclea r ant ibody assay on a mouse kidney 
section substrate, but a pa rticulate nuclear sta ining pat te rn on human 
Hep-2 cell substrate. Sera from normal humans were used as a control. 
Cells 
The cells stud ied were WiL2, an Epstein -Ba rr virus-transformed cell 
line of continuously growing human diploid 8 lymphocyte: origina lly 
obta ined from the splee n of a patient with heredita ry spherocytos is 
[21] . The cells were mainta ined in suspension cu lture wi th minimal 
esse ntial mediu m (MEM) supplemented with 10% heat -inact ivated 
feta l bov ine se rum , MEM -nonessent ia l amin o ac ids, MEM-vita min s, 
sodium pyruva t·e, and 2 mM glu ta mine a nd antibi otics (C.ibco, Buffalo, 
New York ). The ce ll s were subcultured a t. a concentration of 2 x 10"/ 
ml eve ry 3 days. 
Cell Ext ract 
An eq ual amou nt of phosp hate- buffered sa line was added to packed 
WiL2 cell pellets plus 1 mM phenyl methyl sul fo nyl flu oride. The whole 
suspe nsio n was then subjected to ult rason ication to disrupt the cells. 
T he supe rnata nt, after cla rification wit h ce nt ri fuga l ion ( 100,000 fi X 
80 min ), was then used as t he crude an tigenic ma t.eri al for furth er 
pa rt ia l purification and doubl e immunodiffusion analys is. 
Procedures fvr Partial Purification. 
The WiL2 cell ex trac t was subjected to sa lt fra ct ionation with 
differenti al sequenti al saturated ammonium sulfate solu t ion. Saturated 
ammonium sulfate (SAS) solu tion was <J dded gradua lly to the cell 
extrac t to yield a :30 % saturated so lution. The precipit.ate (30% SAS 
ppt fraction) was co llected afte r centrifuga l ion a t I 0,000 fi for 30 min 
and more SAS so lution was added to produce 50% sa turation. The 
precipita te (50% SAS ppt fraction) was collected and more SAS solu-
t ion added to yield 66% saturation. Simila rly t hi s 66% SAS ppt fraction 
was co llected and fin a lly a 100% SAS ppt frac tion was a lso obta ined . 
The different ppt frac tions were t hen dissolved in small amoun ts of 
phosphate-buffered saline which were then assayed in double immu-
nocli!Tusion and counte rimmun oe lect rop horesis fort he presence of SS-
B/La or SS-A/ Ro antige nic activit ies . The 50- 66% SAS ppt fraction, 
whi ch co nta ined SS-8 / La and SS-A/Ro antige ns, was t hen applied 
onto a G-200 ge l fil t ration co lumn (diameter 2.6 em, length 60 em). 
Afte r count erimmunoe lectrophoresis for analyzin g the antigenic ac tiv-
ity of SS-8/La and SS-A/ Ro, the seco nd pea k conta ining both anti-
genic act ivit ies was collected, concentrated, and applied onto a DE-52 
ion exchange chromatography column using phosphate buffer 0.0 1 M, 
p H 8.0. The bound substa nces were elu ted from t he DE -52 co lu mn 
us in g NaCl gradients. The fractions conta ining the a ntigenic activit ies 
fo r SS-8/ La and SS-A/ Ro from 0.3 M NaC I gradient eluate were pooled, 
co ncent rated. and appli ed onto a 10% polyacry lamide gel elect ropho-
resis under native condi t ion relative to protein . The ge l was then sliced 
into 5 mm ·wide pieces and extracted in Tris-HCl buffe r pH 7.6. SS-B/ 
La and SS-A/Ro ant igenic activit y in t hese eluates was moni to red by 
cou nterimrnun oelecl rophoresis. One part of the ge l was stain ed wi th 
Coomassie Brilliant Blue and the prote in profile was scanned using a 
densitometer. 
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Radiolabeling of Cell:; and Preparations of Cell Extract for 
lmmu.rwprecipitation 
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Two- to three-day-old WiL2 cells we re used in the immunoprec ipi-
tation ex periments. Cells were labeled with ["2Pj phosphoric ac id at a 
conce ntration of 2 x 107 ce lls/! mCi for 15 h (50 ,.,Ci/ ml ). T he labeling 
was ca rried out in a medium of phosphate- free MEM, (Flow Labora-
to ry, Ca lifornia) and supplemented wi th 2 m M glutamine, antibiotics, 
and 10% heat-inactivated feta l calf serum. Afte r labeling, the ce ll s were 
was hed twice with 50 mM Tris, .1 50 mM NaCI, pH 7.4, and resuspended 
into the sa me buffered solu t ion at the concent ration of 2 X 107 /m i. T he 
cells. were then disrupted extensively by ul t rasonication. T he ce ll su-
pernatant afte r cla rification by cent ri fugation at 12,000 g for 20 min , 
was collected as the source of radio labeled antigen. 
lmmunoprecipitalion of Protein -RNA Complexes 
T he '12P-labeled WiL2 cell extract was used in the im munoprecipi -
tation, and t he RNA and phosphop rotein components of the immu ne 
complexes were analyzed using the met hods described ea rlier by Pize r 
etal[ 15 j. 
Jmmunoblot An.aly:~ ~~~ 
Eit her the crude WiL2 cell extract or t he part ially purified materials 
were subjected to 10% sod ium dodecy l sul fate (SDS)-polyacrylamide 
gel electrophoresis. After electrophoresis, t he proteins were blotted 
onto nitrocellulose paper according to the method described by Burnett 
[22 ]. Thereafter, the ni t rocellulose paper was soaked in a monospecific 
serum dilu tion conta ining eit her anti-SS-8 / La or SS-A/ Ro antibodies 
fo llowed by a horseradish perox idase (HRP)- labeled goat anti huma n 
lgG solu t ion (Cappel Company) . After incubation, the ni trocellulose 
paper was was hed extensively in Tris-HCl-NaCl so lut ion, pH 7.4 , and 
t he coloring reagent. (substrate solu tion) of hydrogen pe roxide and 4-
chloro-l -naph thol was added. T he colored ba nd indicated the reactive 
peptide location. Four different sera contai ning SS-8/ La or SS-A/ Ro 
prec ipi tin antibodies were used in t his assay. 
RESU LTS 
Coexistence of SS-8/Lo and SS-A/Ro Antigenic Activities 
S ixty millili te rs of WiL2 cell ext ract was subjected to d iffe r-
en t ia l bioche mica l puri!ication procedures in order to get. pa r-
t ia lly puri fied a n t ige nic prepa ra tions . As shown in Table I, t he 
bulk o f SS-B/ La an t igenic mate ria ls was recovered from a wide 
ra n ge o f a mm onium sul fate- prec ip itated fractions. SS-A/Ro 
a n t ige nic activi ty, howeve r, was recovered o nly from t he frac-
tions prec ipi tated by 30- 50 % a nd 50- 66% S AS so lut ions. Both 
a n t ige ni c materi a ls we re presen t in t he 30- 66% S AS-precipi -
ta ted fractions, while SS-B/ La was a lso present in t he fract ion 
t hat did not conta in de tectable SS-A/Ro activi ty (66- 100% ). 
The fraction precipitated by 30- 50 % SAS solut ion a lso con -
ta ined S m a nd nRN P a nti ge nic act ivity a nd the refo re was not 
used fo r fur t he r puri!i cation . t he 50- 66% S AS solut ion -p rec ip-
itated fraction (total prote in 150 mg) was t hen applied onto G-
200 gel fil t ration co lumns a nd t he SS-B/La a nd SS-A/ Ro 
a nti geni c activit ies we re recove red in t he fractions prese n t in 
second pea k as demo nstra ted in Fig 1. Fractions from t he 
second pea k we re collected, poo led, conce ntrated (total p rotein 
30.5 mg), a nd a pplied on to a DE-52 ion exc ha nge column us ing 
phosphate buffe r 0.01 M , pH 8.0. T he bound m ate ria ls we re 
e lu ted wit h N aC l gradien ts and t he e lution profil es a re illus-
t rated o n Fig 2. SS-B / L a a nt igenic activity can be detected in 
fractions e luted wi t h 0. 1, 0.2, 0.3, a nd 0.5 M N aCl gradien ts 
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whi le SS-A/ Ro can be detected only in the fractions elu ted 
with 0.2 and 0.3 M NaCI gradients. Since the 0.3 M NaCI 
fract ion co ntained a lower protein concent ration and was rel-
atively enriched for SS-A/Ro and SS-B/La activities, t his 
fraction (tota l protein 3 mg) was further fractionated by 10% 
acrylamide gel electrophoresis under native condi t ions (i.e., 
without SDS) . T he electrophoresed protein profile is shown in 
Fig 3. The right-hand side was the dye front and the left -hand 
side was the stacking gel. In th is native gel condi t ion , the 
separation of prote in was based on t he molecular weight and 
charge of the prote in molecules. After electrophoresis, SS-B/ 
La and SS-A/Ro were found in the same fraction ranges, as 
indicated in Fig 3, though SS-B/La was also present in some 
fract ions not having detectable activity of SS-A/Ro. 
RNA Profiles Associated with the Respective Nuclear Antigens 
Sequential immunoprecipitation using 32P-Iabeled cell ex-
t ract and monospecific sera was performed. T he respective 
antigen-associated RNA profiles a re shown in Fig 4. Lanes 1 
and 2 represent SS-B/La and SS-A/Ro, respectively. SS-B/La 
antibodies could bring down 7 RNAs. Two of them were similar 
to EBER electrophoret ically; two others were similar to 58 
RNA and 4.58 RNA. Anti-SS-A/ Ro antibodies were associated 
with 4 RNAs as shown in lane 2 in Fig 4. Lanes 3 and 4 show 
~ 11 
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0 j 
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l<'I G 1. G-200 gel filtration protein elut ion profi le. The original ma-
teria l was from the fractions precipitated with 50- 65 % SAS solu t ion. 
The SS-A/ Ro a nd SS-B/ La were present in t he second peak fractions, 
based on counterimmunoelectrophoresis. Fraction number is indicated 
on abscissa . 
Vol. 84, No.2 
the RNA profiles for Sm and nRNP, respectively. Sm was 
fou nd associated with at least 5 differen t RNAs and t he most 
abundant were U1 and U2 RNAs, while nRNP was associated 
with Ul RNA primarily. Lane 5 was t he normal human serum 
control which did not bring down specific RNA. 
Distinct Phosphoprotein.s Associated with the SS-B/ La and 
SS-A/Ro Antigens 
Fig 5 shows t he SS-B/La and SS-A/Ro antigen-associated 
phosphoprotein profiles. Lanes 1 and 2 show t hat anti -SS-B/ 
La antibodies are associated wit h a distinct 43K pept ide con -
taining phosphoamino groups. Sim ila rly, anti-SS-A/Ro an ti-
bodies can also bind to a 43K phosphoprotein as shown in lanes 
3 and 4. This 43K peptide was not bound by normal human 
serum (lane 5), anti-Sm (lane 6), nor anti-nRNP (lane 7). Anti-
Sm and anti-nRNP ant ibodies bound commonly to 3 phospho-
proteins, while ant i-Sm also bound to a distinct phosphoprote in 




F IG 3. P rotein sca nning profi le of preparat ive 10% polyacrylamide 
gel electrophoresis. The start ing mater ial was obtained from fract ions 
eluted with 0.3 M NaCl gradient in DE-52 ion exchange chromatogra-
phy. 
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FIG 2. Protein elut ion profile from 
DE-52 ion exchange -chromatography 
wi t h phosphate buffer 0.0 1 M , pH 8.0. 
The sta rting mate rial was obtained from 
t he second peak fractions of G-200 gel 
fi ltration column eluate. Ini t ia lly 500 ml 
phosp hate buffer was used to was h out 
all t he unbound substances (A) , t hen the 
fo llowing were applied: 500 ml phosphate 
buffer with 0.1 M NaCl gradient (B), 500 
ml phosphate buffer with 0.2 M NaCI 
gradient (C), 500 ml phosphate buffer 
with 0.3 M NaCl gradien t (D) , and fi -
nally 500 ml phosphate buffe r wit h 0.5 
M NaCl gradient (E), and used to elute 
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FIG 4. Cellular antigens associated RNA profiles. "2P-labeled WiL2 
cell extract was added to specifi c serum and then Pansorbin (Staph. 
aureus) added. T he immune complexes were then eluted out from the 
Staph. au.reus with SDS containing T ris-HCl buffe r and then treated 
with proteinase K and subjected to 7 M cerea-10% acrylam ide gel 
electrophoresis. Lane I, SS-8/La-associated RNAs. Lane 2, SS-A/Ro-
associated RNAs. Lane 3, Sm-associated RNAs. Lane 4, nRNP-asso-
ciated RNA. Lane 5, Normal human serum control. 
2 3 4 5 6 7 
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FIG 5. Cellular antigen-associated phosphoprotein profiles. 32P-la-
beled WiL2 cell extract was added to specific serum and then Pansorbi n 
(Staph. aureus) added. The immune complexes were then subsequently 
eluted out from the Staph. au reus with SDS co ntaining Tris-HCI buffer 
and then treated with RNase subjected to 10% SDS-polyac rylamide 
gel electrophoresis. Lanes I and 2, SS-8/La-associated phosphopro-
teins. Primarily a 43K phosphop rotein was fo und associated with SS-
8/La. Lanes 3 and 4, SS-A/Ro-associated phosphoprotein profil es. 
T his 43K peptide was not bound by normal human serum (lane 5), 
anti-Sm (lane 6); nor anti -nRNP (lane 7) . 
Peptides Reacting Specifically with Anti-SS-B/La and A nti-
SS-A/Ro A ntibodies 
When t he WiL2 ce ll extract was analyzed by t he immunoblot 
technique, as shown in F ig 6, lane 3, an t i-SS-B/La antibodies 
were found to react wit h a specific pep tide of molecular weight 
43K. Ant i-SS-A/Ro an t ibodies, however , reacted wit h a 60K 
pep t ide (Fig 6, lane 4). Fou r diffe rent sera contain ing SS-B/La 
and SS-A/Ro precipit in antibodies were used and a ll showed 
t he same kind of reactivity. Lane 1 con tains the molecular 
weight standards and lane 2 represents t he protein p rofile of 
t he crude Wi12 cell ext ract. When the partia lly purified ma-
teria ls were used in t he immunoblot analysis, a 60K pept ide 
was cons istent ly observed and recognized by an t i-SS-A/Ro 
a nt ibodies (data not shown). However, when fractions from 
d iffe ren t steps of purification were used, ant i-SS-B/La an t i-
bodies reacted wit h other peptides of lower molecular weight, 
as shown in Fig 7. Lane 1, obtained from crude WiL2 cell 
extract, showed t hat 43K pept ide reacted wit h ant i-SS-B/La 
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antibodies. T his indicated that the SS-B/La an t igen is a pep-
t ide of mo lecular weight of 43K. As t he cell extract was sub-
jected to ammoni um sulfate fractionation (lane 2) and DE-52 
ion exchange chromatography (lane 3), t he intensity of the 43K 
peptide band decreased a nd 3 or 4 lighter protein bands were 
detected. One band of 30K peptide gradually increased in 
intensity. When fractions from preparative 10% polyacryl-
amide gel electrophoresis were used, only t he 30K peptide was 
recognized by the anti-SS-B/La antibodies (lane 4). Similarly, 
30K peptides from partia lly purified rabbit thymus extract was 
recognized by the an ti -SS-B/La antibodies (lane 5) . 
DISCUSSION 
SS-B/La and SS-A/Ro cellular antigens have been found by 
others to be associated with distinct small cellula r RNAs. We 
have foun d t hat SS-B/La is associated with 7 RNAs in our 
experimental system using cellular extract from WiL2 cells-
an Epstein-Barr virus t ransformed cell line. As has been shown 
previously, SS-B/La is associated with at least 4 RNAs from 
cells not infected with adenovirus, or Epstein-Barr virus 
[4,15]. Two of t he RNAs are 58 RNA and 4.58 RNA [6,8,9] . 
T he other 2 RNAs are still unidentified and needed to be 
further defined. W hen aden ovirus-in fected cells have been 
used, VA-RNA have been foun d to be strongly associated with 
SS-B/La a n t igen [4,15]. In addit ion , other small RNAs synthe-








FIG 6. Protein profile of WiL2 cell extract and the immunoblot 
profi les fo r SS-8/La and SS-A/ Ro. Lane I, Molecular weight standard. 
Lane 2, Protein profil e of WiL2 cell extract. WiL2 extract was subjected 
to 10% SDS-polyacrylamide gel electrophoresis and then blotted onto 
nitrocellulose paper (lane 2). After blotting some were reacted with 
anti-SS-8/ La monospecific serum (lane 3) and some with anti-SS-A/ 
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FIG .7. Immunoblot analysis for SS-B/ La cellular antigen. Antigenic 
preparations from different preparations were subjected to 15% SDS-
polyacrylamide gel electrophoresis, blotted onto nitrocell ulose paper, 
treated with anti-SS-8/ La antiserum, and then HRP- labeled goat 
antihuman .lgG. Lane I , From crude WiL2 cell extract. Lane 2, From 
ammonium sulfate-precipitated fract ions. Lane 3, From DEAE ion 
exchange chromatography fraction. Lane 4, From fractions eluted from 
10% preparative acrylamide gel electrophoresis. Lane 5, From partially 
purified fractions from rabbit thymus extract. 
90 DENG, SONTHEIMER, AND GILLIAM 
sized by cell s infected with adenovirus have a lso been found to 
be associated with SS-B/La antigen as confirmed by RNA-
DNA hybridization [15]. Sim ilarly, when Raji cells and WiL2 
cells (both are transformed by Epstein-Barr virus) have been 
used, 2 additional RNAs have been found bound to SS-B/La 
antigen and have been designated EBER I a nd II [5 ,7]. Our 
studies have shown that the SS-B/La-associated RNAs are 
different from those associated with SS-A/Ro (Fig 4, lane 2), 
Sm (Fig 4, lane 3), or nRNP (Fig 4, lane 4). Some of the SS-
B/La molecules seemed to be related to SS-A/Ro molecules 
[6] . There a re possibly 2 forms of SS-B/La antigen. One is a 
free SS-B/La antigen which contains a 43K peptide and SS-
B/La-associated RNAs. The second form of SS-B/La antigen 
contains SS-A/Ro peptide, SS-A/Ro-associated RNAs, and the 
43K peptide. This might be related to the fact t hat SS-A/Ro is 
present in few copies per cell (4). This hypothesis could be 
confirmed by using monoclonal antibodies against SS-B/La 
and SS-A/Ro antigen. The 43K peptide is the core molecule 
present in both forms of SS-B/La antigens. The 43K peptide 
is also t he antigenic peptide for SS-B/La. This is similar to the 
results reported earlier [9,13,15- 17,19] In the present report, 
SS-B/La was a lso found to be assoc iated with other peptides 
when a nalyzed on immunoblot analysis, including a 30K pep-
tide. We believe that the 43K peptide is unstable and is sensitive 
to spontaneous degradation or proteolytic digestion, as sug-
gested by Venables et al [19). As seen in Fig 7, lane 1, only the 
43K peptide band is recognized by SS-B/La antibody. When 
WiL2 cell extract was subjected to ammonium sulfate precipi-
tation, seen in F ig 7, lane 2, 4 more light bands were detected. 
This indicates that the 43K peptide is degraded gradually. 
When the preparation is further purified with DE-52 ion ex-
change chromatography, more of the 43K peptide is degraded 
and finally on ly the 30K peptide is detectable after preparative 
polyacrylamide gel electrophoresis. When a preparation from 
rabbi t thymus extract was used, on ly the 30K peptide was 
found . This could explain the difference in molecular weights 
for SS-B/La that have been reported in the past several years 
[9,13,15-17). 
Recent evidence has suggested that SS-B/La can a lso bind 
to some precursors of 58 RNA [8], which is a product of 
ribosomal RNA. The distribution of SS-B/La is strongly asso-
ciated with the cell cycle [2]. SS-B/La is present in the nucleo-
plasm of cells in t he resting phase. It is a lso present in the 
nucleolus of cells during the late G1 to early S phases of the 
cell cycle, a phase in which rapid synthesis of ribosomal RNA 
occurs. These observations suggest SS-B/La may have a func-
tional role related to ribosomal RNA synthesis. 
The nature of SS-A/Ro is still unknown. As shown in Fig 6, 
lane 4, the molecular weight of SS-A/Ro peptide is around 60K. 
This is similar to that described recently by M. Reichlin eta! 
(personal communication). Its presence in the cellular extract 
is frequently associated with SS-B/La from which separation 
is difficult. This kind of molecular association between SS-A/ 
Ro and SS-B/La might give rise to the s imultaneous coexist-
ence of two autoantibodies-anti-SS-B/La and anti-SS-A/ 
Ro- in certain patients with various connective tissue diseases. 
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